PortViewPortView
LENZ Therapeutics logo

LENZ Therapeutics (LENZ) Stock Analysis

NASDAQHealthcareBiotechnology

$5.34+2.01%
1-year price historyRange $4.59 – $49.05
52-week range$5.34
$4.54$50.40

What LENZ Therapeutics does

LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.

Key metrics

Market cap
$167.28M
P/E (TTM)
-1.30
EPS (TTM)
$-4.09
Beta
1.63
Dividend yield
0.00%
Revenue / share
$0.68
50-day avg
$5.27
200-day avg
$11.82
52-week high
$50.40
52-week low
$4.54
CEO
Evert Schimmelpennink

ETFs linked to LENZ

Broad-market and Healthcare sector ETFs an investor holding LENZ Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how LENZ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LENZ in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for LENZ Therapeutics?
LENZ Therapeutics trades under the ticker LENZ on NASDAQ.
Which exchange is LENZ listed on?
LENZ is listed on NASDAQ.
What sector does LENZ Therapeutics operate in?
LENZ Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze LENZ in a portfolio?
PortView shows LENZ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.